The AACE update to its 2026 algorithm for the management of type 2 diabetes includes a new section on diabetes classification ...

A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help ...

A University of Virginia Center for Diabetes Technology-developed algorithm – paired with a continuous glucose monitor – can ...

The usefulness and relevance of diabetes clinical guidelines are beyond doubt. Their use is widespread among internal medicine clinicians, though they have a weakness: “The most relevant information ...

The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...

A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...

The Food and Drug Administration recently approved Belgium-based Janssen Pharmaceuticals’ drug Invokamet XR for first-line use to improve glycemic control in diabetic adults when paired with diet and ...

A BMJ guideline put patient risk into the equation for assessing the suitability of SGLT-2 inhibitors and GLP-1 receptor agonist drugs for type 2 diabetes. Their use in type 2 diabetes was only ...

The first-in-class injectable could be the next big thing in diabetes and obesity treatment.

Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat obesity as the chronic, relapsing disease that it is.While lifestyle ...

When diabetes causes CKD, it’s sometimes called diabetic kidney disease. Elevated blood sugar levels that result from diabetes can damage the tiny blood vessels inside your kidneys. As a result, your ...